Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. Their use in disease diagnosis and treatment has proven very beneficial over the past number of years as their use as biomarkers has been adopted as a means to understanding disease and therapies. They have expanded into more disease relevant, specialized panels for a more accurate assessment of various diseases that include cardiovascular disease, asthma, inflammation, cancer, diabetes, and rheumatoid arthritis.
AbbVie accounted for 16.38% of the cytokines revenue market share in 2015. AbbVie, Johnson & Johnson, GlaxoSmithKline, Novartis and Roche are the key players and accounted for over 39.63% of the overall insect repellent market share in 2015.
Global giant manufactures mainly distributed in North America and Europe. They have unshakable status in this field. North America takes the revenue market share of 41.82% in 2015, Europe followed by with 30.69% in 2015. Particularly, there is hardly a large enterprise and market is very fragmented.
The market is not only influenced by the price, but also influenced by the product performance. The leading companies own the advantages on better performance, more abundant product?s types, better technical.
Looking to the future years, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.
Despite the presence of competition problems, due to the global recovery trend is slightly, investors are still optimistic about this area; the future will still have more new investment enter the field.
According to this study, over the next five years the Cytokines market will register a 16.5% CAGR in terms of revenue, the global market size will reach USD 297500 million by 2024, from USD 119000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cytokines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cytokines market by product type, application, key manufacturers and key regions and countries.
This study considers the Cytokines value and volume generated from the sales of the following segments-
Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
TNF
IL
IFN
EGF
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer and Malignancy
Asthma / Airway Inflammation
Arthritis
Others
This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
AbbVie
Johnson & Johnson
GlaxoSmithKline
Novartis
Roche
Pfizer
Sanofi
Bayer HealthCare Pharmaceuticals
Thermo Fisher Scientific
Biocon
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cytokines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cytokines market by identifying its various subsegments.
Focuses on the key global Cytokines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cytokines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cytokines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
